Sunday, 16 June 2019

Pharma News

  • Scotland approves Eisai's Fycompa

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2013

    Singapore: Eisai announched that Scotland's health technology assessment (HTA) body, the Scottish Medicines Consortium (SMC), has approved Eisai's AMPA receptor antagonist Fycompa (perampa...Read more

  • India's new pharma pricing policy will be a profitability challenge: Glenn Saldanha

    Pharma |  Opinion | By BioSpectrum Bureau  | 0 Comment | 20 May, 2013

    The Indian pharmaceutical industry has witnessed a healthy growth in the last decade, driven by factors like rising consumption levels in the country and strong demand from export markets. ...Read more

  • RLS, Parkinson's drug Neupro gets Japanese nod

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 28 Dec, 2012

    Singapore: The Japanese Ministry of Health, Labour and Welfare (MHLW) has approved Neupro (rotigotine transdermal patch) for the treatment of Parkinson's disease (PD) and for the symptomat...Read more

  • AVEO, Astellas cancer drug gets FDA nod

    Pharma |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 29 Nov, 2012

    Singapore: AVEO Oncology and Astellas Pharma announced that the US Food and Drug Administration (FDA) has accepted for filing the New Drug Application (NDA) for tivozanib with the propo...Read more

  • Mundipharma, Shionogi tie up for pain treatment in Japan

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 22 Nov, 2013

    Singapore: Mundipharma has entered a license agreement with Japan-based Shionogi for the exclusive rights to develop, manufacture and commercialize the abuse deterrent formulation of Oxycod...Read more

  • China Biologic adopts stockholder rights plan

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2013

    Singapore: China Biologic Products, a leading fully integrated plasma-based biopharmaceutical company in China, announced that its board of directors has adopted a stockholder rights plan....Read more

  • Cipla acquires 51 percent stake in Yemen

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 05 Jul, 2014

    Singapore: Given the recent preference to local manufacturing, this secures the company's presence in a fast growing market. Cipla already has a leading position in Yemen with over 200 pro...Read more

  • Bayer to buy Chinese firm Dihon Pharma

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 28 Feb, 2014

    Singapore: Germany's leading pharmaceutical company, Bayer has said that it is planning to acquire Chinese pharma firm Dihon Pharmaceutical Group as part of its global growth plan. The pha...Read more

  • ScinoPharm CEO retires, firm's VP to succeed

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 14 Jul, 2014

    Singapore: Taiwan-based pharmaceutical company ScinoPharm announced the retirement of its chief executive officer, Dr Jo Shen. Dr Shen would be retiring by the end of July, following 17 yea...Read more

  • Diabetes specialist Amylin is on sale for $4.3bn

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 04 Jun, 2012

    Singapore: Diabetes company Amylin, which steered away a $3.5 billion takeover bid from Bristol-Myers Squibb (BMS) earlier this year, is expected to enter into a second round of bidding in ...Read more

  • Boehringer heart drug is particularly effective in Asian population

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 13 Sep, 2012

    Singapore: Boehringer Ingelheim has reported that in Asian populations, Pradaxa (dabigatran etexilate) offers considerable benefits for the management of patients with atrial fibrillation (...Read more

  • Sanford-Burnham, Daiichi form new alliance

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 26 May, 2014

    Singapore: US based Sanford-Burnham Medical Research Institute and Japan's Daiichi Sankyo have formed a three year discovery and pre-clinical drug development partnership for cardiovascular...Read more

  • Boehringer, Eli Lilly to evaluate Trajenta for type 2 diabetes

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 21 Mar, 2013

    Singapore: Boehringer Ingelheim and Eli Lilly have initiated phase IIIb trial to evaluate the glycaemic efficacy and safety of linagliptin in type 2 diabetes patients with prevalent albumin...Read more

  • Pharma giants warn Korea of low drug pricing

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 07 Jul, 2014

    Singapore: International pharma companies are concerned about the low pricing of their drugs in the Korean markets and have warned Seoul that they are holding back new medicines from the co...Read more

  • Astrazeneca, China university in research deal

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 19 Dec, 2012

    Singapore: AstraZeneca has signed a research collaboration with Fudan University, one of China's leading academic institutions in the area of cardiovascular diseases (CVDs). CVDs are a lead...Read more

  • India to soon decide on FDI policy in pharma

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 13 Aug, 2013

    Singapore: Ahead of the raging issue of Foreign Direct Investment (FDI) in the pharmaceutical sector in India, the country's finance minister P chadambaram has said that the government woul...Read more

  • Bio & Medical Korea 2014: Global healthcare tourism event

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2013

    Singapore: Bio and Medical Korea 2014 an international event of the medical industry, was held over three days beginning on May 28 at Kintex in Gyeonggi Province, northwest of Seoul. The ev...Read more

  • Takeda strives to enter Europe's type 2 diabetes market

    Pharma |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 21 Jun, 2012

    Singapore: Japan-based Takeda Global Research & Development Centre has received confirmation of the acceptance of submissions of marketing authorisation applications (MAAs) from the Eur...Read more

Podcast

 

Survey Box

Is Asia becoming the centre of healthcare transformation?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls